scholarly journals The horn bases of the Reedbuck Redunca arundinum

Koedoe ◽  
1975 ◽  
Vol 18 (1) ◽  
Author(s):  
H. Jungius ◽  
C.P. Claussen ◽  
W. Germany
Keyword(s):  
Structure And Function ◽  
Glandular Secretion ◽  
Display Behaviour ◽  
And Function

The structure and function of the horn bases of the reedbuck Redunca arundinum are discussed. It is shown that the white colouration which often occurs is not caused by glandular secretion but by small horn particles which are shed, exposing the lighter coloured material underneath. The shining horn base probably plays a role in the display behaviour of males.

Biological control over the formation and storage of amorphous calcium carbonate by earthworms

2008 ◽  
Vol 72 (1) ◽  
pp. 227-231 ◽  
Author(s):  
M. J. I. Briones ◽  
E. López ◽  
J. Méndez ◽  
J. B. Rodríguez ◽  
L. Gago-Duport
Keyword(s):  
Electron Microscopy ◽  
Biological Control ◽  
Calcium Carbonate ◽  
Ostwald Ripening ◽  
High Resolution Electron Microscopy ◽  
Amorphous Calcium Carbonate ◽  
Concentrated Suspension ◽  
Selected Area Electron Diffraction ◽  
Resolution Electron ◽  
Glandular Secretion

AbstractThe earthworm calciferous gland produces a concentrated suspension of calcium carbonate and in certain species precipitates as concretions of CaCO3, which then enter the soil. Here we investigated the initial stages of CaCO3 formation in the earthworm Lumbricus friendi by means of Fourier transform infrared and electron microscopy techniques (field-emission scanning electron microscopy, transmission electron microscopy, high resolution electron microscopy and selected area electron diffraction). In addition, comparisons between the IR spectra of the water-dissolved carbonic anhydrase (CA) and the glandular secretion (‘milky fluid’) were performed in order to investigate the mechanisms involved in CaCO3 precipitation. Our results strongly suggest that carbonation starts with the dissolved CO2, which is transformed via deprotonation to HCO3-, then to CO32- and finally to amorphous calcium carbonate (ACC). While ACC stabilization takes place under the biological control, further transformation stages leading to calcite concretions seem to be inorganically driven by an Ostwald ripening process.

M1 and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro

1992 ◽  
Vol 73 (5) ◽  
pp. 2069-2073 ◽  
Author(s):  
J. Mullol ◽  
J. N. Baraniuk ◽  
C. Logun ◽  
M. Merida ◽  
J. Hausfeld ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Muscarinic Receptor ◽  
Enzyme Linked Immunosorbent Assay ◽  
Receptor Subtypes ◽  
Muscarinic Antagonists ◽  
Muscarinic Receptor Subtypes ◽  
Mucus Production ◽  
Glandular Secretion ◽  
M3 Receptor

Mucus glycoproteins (MGP) are high-molecular-weight glycoconjugates that are released from submucosal glands and epithelial goblet cells in the respiratory tract. Muscarinic receptors have an important role in the regulation of human nasal glandular secretion and mucus production, but it is not known which of the five muscarinic receptor subtypes are involved. The effect of nonselective and M1-, M2-, and M3-selective muscarinic antagonists on methacholine (MCh)-induced MGP secretion from human nasal mucosal explants was tested in vitro. MGP was assayed by enzyme-linked immunosorbent assay using a specific anti-MGP monoclonal antibody (7F10). MCh (100 microM) induced MGP secretion up to 127% compared with controls. MCh-induced MGP release was significantly inhibited by atropine (100 microM), the M, receptor antagonist pirenzepine (10–100 microM), and the M3 receptor antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP; 1–100 microM). 4-DAMP significantly inhibited MCh-induced MGP release at a lower concentration (1 microM) than pirenzepine (10 microM). The M2 receptor antagonists AF-DX 116 and gallamine (both at 100 microM) had no effect. No antagonist alone had a significant effect on MGP release. These results indicate that the M1 and M3 muscarinic receptor subtypes regulate MGP secretion from human nasal mucosa and suggest that the M3 receptor has the predominant effect.

Neuropeptides and nasal secretion

1991 ◽  
Vol 261 (4) ◽  
pp. L223-L235 ◽  
Author(s):  
J. N. Baraniuk ◽  
M. Kaliner
Keyword(s):  
Nasal Mucosa ◽  
Defense Mechanism ◽  
Sensory System ◽  
Sensory Nerve ◽  
Sympathetic Nerves ◽  
Mucosal Injury ◽  
Sensory Nerves ◽  
Neurokinin A ◽  
Sympathetic Nervous Systems ◽  
Glandular Secretion

The nasal mucosa is innervated by the sensory, parasympathetic, and sympathetic nervous systems. Nociceptive sensory nerves are stimulated by mucosal injury, inhalation of irritants, or mast cell degranulation and release of the calcitonin gene-related peptide, the tachykinins substance P and neurokinin A, and other peptides by the axon response mechanism. Sensory nerve stimulation initiates systemic reflexes, such as the sneeze, and central parasympathetic reflexes which release acetylcholine, vasoactive intestinal peptide, and other peptides and lead to glandular secretion. In concert, these proinflammatory neural responses lead to vasodilation, vascular permeability, and glandular secretion. Sympathetic nerves release neuropeptide Y and norepinephrine, potent vasoconstrictors which act to decompress the nasal mucosa and produce nasal patency. The balance between the effects of parasympathetic and sympathetic neurotransmitters may regulate nasal homeostasis, whereas the nociceptive sensory system may be held in reserve as a defense mechanism. Dysfunction of these systems may lead to pathological nasal syndromes. In the future, specific neuropeptide agonists and antagonists may be useful for the treatment of human rhinitic diseases.

Intramolecular Michael Addition of N- and O-Centred Nucleophiles to Tethered Acrylates. The Role of Double-Bond Geometry in Controlling the Diastereo- selectivity of Cyclizations Leading to 2,6-Disubstituted Tetrahydropyrans and Piperidines.

1998 ◽  
Vol 51 (1) ◽  
pp. 9 ◽  
Author(s):  
Martin G. Banwell ◽  
Brett D. Bissett ◽  
Chinh T. Bui ◽  
Ha T. T. Pham ◽  
Gregory W. Simpson
Keyword(s):  
Double Bond ◽  
Total Synthesis ◽  
Michael Addition ◽  
Reductive Amination ◽  
Major Product ◽  
Enantioselective Synthesis ◽  
Cyclization Reactions ◽  
Glandular Secretion

The oxyanion derived from hydroxyacrylate E-(5) undergoes smooth intramolecular Michael addition to give the trans-2,6-disubstituted tetrahydropyran (7) as the major product of reaction. In contrast, the oxyanion obtained from isomer Z-(5) cyclizes to give the cis-2,6-disubstituted tetrahydropyran (6) as the major product. Such chemistry has been extended to the enantioselective synthesis of (+)-(6) the acquisition of which constitutes a formal total synthesis of acid (+)-(2), a constituent of the glandular secretion from the civet cat (Viverra civetta). Reductive amination of keto acrylate (12) affords an intermediate amine which cyclizes, in situ, to give the cis-2,6-disubstituted piperidine (26). Analogous treatment of compound (13) delivers the isomeric trans-2,6-disubstituted piperidine (27) as the exclusive product of reaction. Transition state structures have been proposed to account for the diastereoselectivities observed in all of the cyclization reactions.

Neuropeptide Y is a vasoconstrictor in human nasal mucosa

1992 ◽  
Vol 73 (5) ◽  
pp. 1867-1872 ◽  
Author(s):  
J. N. Baraniuk ◽  
P. B. Silver ◽  
M. A. Kaliner ◽  
P. J. Barnes
Keyword(s):  
Neuropeptide Y ◽  
Protein Content ◽  
Vascular Permeability ◽  
Nasal Mucosa ◽  
Total Protein ◽  
Nerve Fibers ◽  
Human Nasal Mucosa ◽  
Nasal Provocation ◽  
Glandular Secretion ◽  
Nasal Secretions

Neuropeptide Y (NPY) is a neurotransmitter in sympathetic nerve fibers in human nasal mucosa. Like norepinephrine, NPY acts as a vasoconstrictor. An established method of nasal provocation was used to determine the effects of topically applied NPY on nasal resistance to airflow measured by anterior rhinomanometry, the protein content of nasal secretions, and the protein content of bradykinin-induced secretions. NPY (2.3 nmol) reduced the resistance to inspiratory airflow by 57 +/- 18% (P < 0.001) in 10 normal subjects and by 50 +/- 17% (P < 0.05) in 12 subjects with perennial rhinitis. In nasal provocations, NPY in doses of 0.1–10 nmol had no effect on vascular (albumin), glandular (lysozyme, glycoconjugate), or total proteins present in lavaged nasal secretions. Because the vasoconstrictor properties of NPY may only be apparent in the presence of increased vascular permeability and albumin exudation, bradykinin (BK) nasal provocation was performed. BK (500 nmol) significantly increase total protein (10- to 20-fold), albumin (10- to 30-fold), and glycoconjugate (2- to 5-fold) in lavage fluid. NPY (2.3 nmol) reduced BK-induced total protein by 59 +/- 15% (P < 0.05) and albumin by 63 +/- 17% (P < 0.02) but had no significant effect on glandular secretion. Therefore exogenous administration of NPY to the human nasal mucosa reduced nasal airflow resistance and albumin exudation without affecting submucosal gland secretion. NPY agonists may be useful for the treatment of mucosal diseases characterized by vasodilation, vascular permeability, and plasma exudation.

scholarly journals Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies

2018 ◽  
Vol 19 (10) ◽  
pp. 3270 ◽  
Author(s):  
Yasuyoshi Miyata ◽  
Hideki Sakai
Keyword(s):  
Molecular Mechanisms ◽  
Royal Jelly ◽  
Biological Activities ◽  
Treatment Strategies ◽  
Protective Effects ◽  
Beneficial Effects ◽  
Glandular Secretion ◽  
Anti Cancer ◽  
The Future ◽  
Queen Honeybee

Royal jelly (RJ) is a glandular secretion produced by worker honeybees and is a special food for the queen honeybee. It results in a significant prolongation of the lifespan of the queen honeybee compared with the worker honeybees through anti-inflammatory, anti-oxidant and anti-microbial activities. Consequently, RJ is used as cosmetic and dietary supplement throughout the world. In addition, in vitro studies and animal experiments have demonstrated that RJ inhibits cell proliferation and stimulates apoptosis in various types of malignant cells and affects the production of various chemokines, anti-oxidants and growth factors and the expression of cancer-related molecules in patients with malignancies, especially in patients treated with anti-cancer agents. Therefore, RJ is thought to exert anti-cancer effects on tumor growth and exhibit protective functions against drug-induced toxicities. RJ has also been demonstrated to be useful for suppression of adverse events, the maintenance of the quality of life during treatment and the improvement of prognosis in animal models and patients with malignancies. To understand the mechanisms of the beneficial effects of RJ, knowledge of the changes induced at the molecular level by RJ with respect to cell survival, inflammation, oxidative stress and other cancer-related factors is essential. In addition, the effects of combination therapies of RJ and other anti-cancer agents or natural compounds are important to determine the future direction of RJ-based treatment strategies. Therefore, in this review, we have covered the following five issues: (1) the anti-cancer effects of RJ and its main component, 10-hydroxy-2-decenoic acid; (2) the protective effects of RJ against anti-cancer agent-induced toxicities; (3) the molecular mechanisms of such beneficial effects of RJ; (4) the safety and toxicity of RJ; and (5) the future directions of RJ-based treatment strategies, with a discussion on the limitations of the study of the biological activities of RJ.

Calcitonin gene-related peptide in human nasal mucosa

1990 ◽  
Vol 258 (2) ◽  
pp. L81-L88 ◽  
Author(s):  
J. N. Baraniuk ◽  
J. D. Lundgren ◽  
J. Goff ◽  
J. Mullol ◽  
S. Castellino ◽  
...  
Keyword(s):  
Nasal Mucosa ◽  
Binding Sites ◽  
Calcitonin Gene Related Peptide ◽  
Nerve Fibers ◽  
Potential Range ◽  
Submucosal Gland ◽  
Human Nasal Mucosa ◽  
Related Peptide ◽  
Glandular Secretion ◽  
Calcitonin Gene

To explore the potential range of functions for calcitonin gene-related peptide (CGRP) in human mucosa, we quantified human inferior turbinate nasal mucosal CGRP content by radioimmunoassay, localized CGRP-immunoreactivity by immunohistochemistry, detected 125I-CGRP binding sites by autoradiography, and tested the ability of CGRP to induce submucosal gland secretion in short-term explant culture of human nasal mucosa. Nasal mucosa contained 0.45-0.54 pmol CGRP/g wet wt (n = 18). Immunoreactive CGRP was found in nerve fibers that densely innervated the walls of small muscular arteries arterioles. Venules and venous sinusoids were innervated by individual CGRP staining fibers. Occasional CGRP-containing nerve fibers were also noted adjacent to submucosal gland acini, near the epithelial basement membrane, and between epithelial cells. Specific 125I-CGRP binding sites were concentrated on small muscular arteries and arterioles. CGRP (4 microM) did not stimulate glycoconjugate or lactoferrin release from mucosal explants. These results indicate that in the human nasal mucosa, CGRP is present in nerve fibers, which most likely represent nociceptive sensorimotor nerves that innervate vascular structures (muscular arteries, arterioles, veins and venous sinusoids). It is likely that CGRP release from sensory neurons may play a role in the regulation of vasomotor responses, but no evidence for a role of CGRP in glandular secretion was found.

532. SOLUBLE MEDIATORS IN THE HUMAN UTERINE CAVITY: POTENTIAL ROLES IN EMBRYO IMPLANTATION

2009 ◽  
Vol 21 (9) ◽  
pp. 130
Author(s):  
N. Hannan ◽  
K. L. Meehan ◽  
L. J. F. Rombauts ◽  
L. A. Salamonsen
Keyword(s):  
Chemokine Receptors ◽  
Embryo Implantation ◽  
Uterine Cavity ◽  
Cycle Phase ◽  
Human Trophoblast ◽  
Endometrial Epithelial Cell ◽  
Glandular Secretion ◽  
Uterine Fluid ◽  
Human Chemokines ◽  
Insight Into

Embryo implantation requires synchronized dialogue between a receptive endometrium and an activated blastocyst via locally produced soluble mediators. During the mid-secretory (MS) phase of the menstrual cycle there is increased glandular secretion into the uterine lumen. These secretions likely contain important mediators that modulate the endometrium and support the conceptus during implantation. Previously we identified that several chemokines were maximally produced during the MS phase by endometrial glandular epithelium (GE) (1, 2) and the presence of chemokine receptors on GE and human trophoblast (3). Furthermore recombinant human chemokines and endometrial epithelial cell-conditioned media stimulated trophoblast migration; this was attenuated by neutralizing specific chemokines (3). Chemokines also regulate a variety of adhesion and ECM molecules on trophoblast (4). Thus chemokines have important roles during embryo implantation. We hypothesized that chemokines are secreted into the uterine cavity and may act on the implanting blastocyst and the endometrium. This study aimed to identify chemokines in uterine fluid (collected by flushing the uterine cavity with 5mls of saline) from fertile women during the proliferative (non-receptive; n=4) and MS (receptive; n=4) phases of the cycle, and from women with unexplained infertility during the MS phase (n=4). Uterine fluid was analyzed using quantitative MilliplexTM Luminex® 42-plex cytokine/chemokine assays revealing the presence of IL-8, CCL2, CCL4, CCL7, CCL11, CCL22 and CX3CL1 in uterine fluid from all women. Importantly chemokine profiles were altered with both cycle phase and fertility; for example CCL4 and CCL22 levels were lower in the infertile cohort, where as CCL2 levels were higher in uterine fluid collected during the proliferative phase. Identifying the soluble mediators in human uterine fluid may provide potential markers of endometrial receptivity, insight into the unique microenvironment essential for pregnancy and a profile of maternal factors that influence the implanting blastocyst.

The Structures of Four Tryptophyllin and Three Rubellidin Peptides From the Australian Red Tree Frog Litoria rubella

1994 ◽  
Vol 47 (11) ◽  
pp. 2099 ◽  
Author(s):  
ST Steinborner ◽  
CW Gao ◽  
MJ Raftery ◽  
RJ Waugh ◽  
T Blumenthal ◽  
...  
Keyword(s):  
Biological Activity ◽  
Western Australia ◽  
Northern Territory ◽  
Tree Frog ◽  
Glandular Secretion ◽  
Different Populations

The peptide content of the glandular secretions of Litoria rubella specimens collected from Derby and Lake Argyle (Kimberley region of Western Australia) and from near Darwin in the Northern Territory are all quite different; this suggests that there are different frog populations in these three areas. These different populations may be indicative of either different species or different sub-species of frog. There are two separate families of peptides in the glandular secretion of 'Litoria rubella': ( i ) those corresponding to the tryptophyllin family (tetra- to hepta -peptides all containing the residues Pro and Trp ), and (ii) the rubellidinins ( pentapeptides all containing two Phe residues at positions 3 and 4). To ate, no biological activity has been found for any of these peptides, but it is suspected that the tryptophyllins may be neurotransmitters or neuromodulators.

Sign in / Sign up

Export Citation Format

Share Document